THE PREVALENCE OF (OMPA, CSUE) GENES AMONG BIOFILM PRODUCER ACINETOBACTER BAUMANNII ISOLATES
DOI:
https://doi.org/10.36103/c5bw0g67Keywords:
Acinetobacter SPP, PCR, Outer membrane protein A, Chaperone -usher pilus.Abstract
Acinetobacter baumannii is a significant public health problem because it is capable of forming biofilms that may be responsible for the survival of this pathogen in the hospital environment. The aim of this study is to determine the role of (OmpA, CsuE) genes in biofilm production among A. baumannii isolates. A total of 100 clinical isolates of bacteria were collected from a different sources. All isolates were identified by biochemical test, specific selective media (CHROMagar) and polymerase chain reaction by detection presence of (blaOXA51) gene. only 60 isolates were diagnosed as A. baumannii, and to determine the biofilm production capacity two different methods were used Congo red agar method(CRA) and Microtiter plate method (MTP). MTP method result showed 85% of isolates were able to form biofilms, on the other hand, 33.33% of isolates had a biofilm production ability by showing bright black colonies on CRA. Conventional PCR was used to detect the presence of (OmpA, CsuE) genes and the result showed the prevalence of both genes in all isolates were 97%(58/60). It also shows a strong correlation between the presence of these genes and biofilm formation.
References
Ali. M., S. S. 2022 . Role of RND-efflux pump in levofloxacin resistance among Acinetobacter baumannii. Iraqi Journal of Agricultural Sciences, 53(3),542-50. https://doi.org/10.36103/ijas.v53i3.1562
Ali. M, S. S. 2020. The role of efflux pump adej gene in levofloxacin resistance among A. baumannii. Systematic Reviews in Pharmacy. 11(10).
Al-Shaabani, M. J. M., A. M., and Al-Mathkhury. 2020. The Anti -biofilm Efficacy of Gold Nanoparticles Against Acinetobacter baumannii. Iraqi Journal of Science. 749-753.
Confer. A., Ayalew S. 2013. The OmpA family of proteins: roles in bacterial pathogenesis and immunity. Veterinary microbiology. 163(3-4), 207-222.
Dahdouh., G.G.R., P. S., M. J., D. Z., and M. Suárez. 2017. Clonality, virulence determinants, and profiles of resistance of clinical Acinetobacter baumannii isolates obtained from a Spanish hospital. PloS one. 12(4), e0176824.
Donadu. M., M. V., C. P., Z. S., M. M., N. Á. L., and M .Gajdács.. 2021. Relationship between the biofilm-forming capacity and antimicrobial resistance in clinical Acinetobacter baumannii isolates: Results from a laboratory-based in vitro study. Microorganisms. 9(11), 2384.
Eze, C. H. Y., and El Zowalaty 2018. Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments. Infection and drug resistance. 11, 2277-2299.
Gunn J., B. L. O., and D. Wozniak. 2016. What's on the outside matters: the role of the extracellular polymeric substance of Gram-negative biofilms in evading host immunity and as a target for therapeutic intervention. Journal of Biological Chemistry. 291(24), 12538-12546.
HS. R., SM. S. 2022. First report in iraq: amino acid substitution in pmrcab genes and there corellation with colistin resistance among a. Baumannii isolates. Iraqi Journal of Agricultural Sciences, 53(2): 237-251. https://doi.org/10.36103/ijas.v53i2.1530
Kafil H., M. A. M., M. M. F., H. Z., and M. Yousefi. 2016. Gentamicin induces efaA expression and biofilm formation in Enterococcus faecalis. Microbial Pathogenesis. 92: 30–35.
Khoshnood S., S. M., M. E. A., and A. Sheikh. 2020. Survey on genetic diversity, biofilm formation, and detection of colistin resistance genes in clinical isolates of Acinetobacter baumannii. Infection and drug resistance .13, 1547.
Kishii K., H. M., A. K., I. K., O. J., I.Y., and K .Tateda. 2020. Differences in biofilm formation and transcription of biofilm-associated genes among Acinetobacter baumannii clinical strains belonging to the international clone II lineage. Journal of Infection and Chemotherapy. 26(7) 693- 698.
Lin M., L. Y.Y.and C. Lan. 2020. Characterization of biofilm production in different strains of Acinetobacter baumannii and the effects of chemical compounds on biofilm formation. PeerJ 8. e9020.
Maryam Kord, A. A., M. J., R. J., N. B., Ezzat G .Allah . 2018. Evaluation of Biofilm Formation and Presence of Ica Genes in Staphylococcus epidermidis Clinical Isolates. Osong Public Health Res Perspect. 9(4):160−166.
Monfared A., R. A., P. F., and J. Faghri 2019. Detection of genes involved in biofilm formation in MDR and XDR Acinetobacter baumannii isolated from human clinical specimens in Isfahan, Iran. Arch Clin Infect Dis .14(2), e85766.
Pakharukova N., T. M., P. S., M. H., P. O., T. S., and A .Zavialov 2018. Structural basis for Acinetobacter baumannii biofilm formation. Proceedings of the National Academy of Sciences. 115(21), 5558-5563.
17. Ramos-Gallardo. 2016. Chronic Wounds in Burn Injury: A Case Report on Importance of Biofilms. World Journal of Plastic Surgery. 5(2), 175–18.
Sato Y., U. Y., M.C., U. T., and Y. Ono. 2019. Multidrug-resistant Acinetobacter baumannii resists reactive oxygen species and survives in macrophages. Scientific Reports. 9(1), 1-12.
Smani Y., M. M. J., and J. Pachón. 2012. Role of fibronectin in the adhesion of Acinetobacter baumannii to host cells. PloS one.7(4), e33073.
Srinivasan R., K. U., V. M., M. J., K. M., M. S., and S. Lynch. 2015. Use of 16S rRNA gene for identification of a broad range of clinically relevant bacterial pathogens. PloS one. 10(2), e0117617.
Sung J. 2018. Molecular characterization and antimicrobial susceptibility of biofilm-forming Acinetobacter baumannii clinical isolates from Daejeon, Korea. Korean Journal of Clinical Laboratory Science. 50(2), 100-109.
Thummeepak R., K. P., L.U., and S. Sitthisak 2016. Distribution of virulence genes involved in biofilm formation in multi-drug resistant Acinetobacter baumannii clinical isolates. Int Microbiol. 19(2), 121-9.
Upmanyu K., H. Q. M., and R .Singh. 2022. Factors mediating Acinetobacter baumannii biofilm formation: opportunities for developing therapeutics. Current Research in Microbial Sciences. 100131.
Vijayakumar S., R. S., L.S., A. S., B. V., and I .Biswas. 2016. Biofilm formation and motility depend on the nature of the Acinetobacter baumannii clinical isolates. Frontiers in public health, 4, 105.
Wang Y., H. T. W., Y.Y. S., K. S. C., C.C. T., L. C. P., and Y. Lee. 2018. Biofilm formation is not associated with worse outcome in Acinetobacter baumannii bacteremia pneumonia. Scientific reports. 8(1), 1-10.
Wedean. G., S. S., and Z. Mahmood. 2022. Diverse stress treatments and acinetobacter baumannii persister formation. Iraqi Journal of Agricultural Sciences, 53(6),1486- 1494.https://doi.org/10.36103/ijas.v53i6.1665
Yang C., S. P. W., M.S. H., and L .Chuang. 2019. Biofilm formation in Acinetobacter Baumannii: genotype-phenotype correlation. Molecules. 24(10), 1849.
Zeighami H., V. F., S. R., S. E., and F .Haghi. 2019. Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients. BMC Infectious Diseases. 19(1), 1-9.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 IRAQI JOURNAL OF AGRICULTURAL SCIENCES
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
2.jpg)
https://orcid.org/0000-0002-5774-5906 2.jpg)
